Home / Science / Metabolic Psychiatry Gains $20M Boost
Metabolic Psychiatry Gains $20M Boost
21 Oct
Summary
- Global Network for Metabolic Psychiatry launches today.
- McLean Hospital receives $20 million Baszucki Group grant.
- New center to advance metabolic approaches to psychiatric care.
The Global Network for the Advancement of Metabolic Psychiatry (MetPsy) has officially launched, unifying global researchers and clinicians. This initiative is bolstered by a new $20 million grant from Baszucki Group, designated for establishing a flagship clinical and research center at McLean Hospital. This center will be instrumental in scaling up metabolic approaches for psychiatric care.
Metabolic psychiatry explores how metabolism impacts brain function and mental health. Emerging research highlights the potential of metabolic treatments, such as ketogenic therapy, in improving symptoms for conditions like depression, bipolar disorder, and schizophrenia. MetPsy aims to serve as a centralized network for collaboration, shared resources, and professional development in this growing field.
The new McLean Center for Metabolic Psychiatry, located in Belmont, Massachusetts, will be directed by Dr. Dost Öngür. It will feature a clinical care center, a research program, and a medical education initiative co-led by MH². This center intends to demonstrate the feasibility of integrated metabolic care and provide a model for other institutions worldwide.
